Registry Study to Evaluate the Performance and Safety of Roxwood Medical Catheters in Arteries of Participants With a Stenotic Lesion or Chronic Total Occlusion (CTO)
- Conditions
- Chronic Total OcclusionAtherosclerosisCoronary Artery DiseasePeripheral Artery Disease
- Interventions
- First Posted Date
- 2019-08-16
- Last Posted Date
- 2021-07-21
- Lead Sponsor
- Boston Scientific Corporation
- Registration Number
- NCT04059536
- Locations
- 🇺🇸
Dignity Health d/b/a St. Joseph's Hospital & Medical Center, Phoenix, Arizona, United States
🇺🇸Cardiovascular Research of North Florida LLC, Gainesville, Florida, United States
🇺🇸St. Mary Medical Center, Inc., Hobart, Indiana, United States
Safety and Effectiveness of Agent Paclitaxel-Coated PTCA Balloon Catheter. (AGENT Japan SV)
- Conditions
- Coronary Artery Disease
- Interventions
- Device: SeQuent Please Drug Eluting Balloon Catheter with Paclitaxel
- First Posted Date
- 2019-08-16
- Last Posted Date
- 2025-05-20
- Lead Sponsor
- Boston Scientific Corporation
- Target Recruit Count
- 180
- Registration Number
- NCT04058990
- Locations
- 🇯🇵
Kokura Memorial Hospital, Kitakyushu, Fukuoka, Japan
🇯🇵Sapporo Higashi Tokushukai Hospital, Sapporo, Hokkaido, Japan
🇯🇵Japan Labour Health and Welfare Organization Kanto Rosai Hospital, Kawasaki, Kanagawa, Japan
Boston Scientific Registry of Deep Brain Stimulation for Treatment of Essential Tremor (ET)
- Conditions
- Essential Tremor
- Interventions
- Device: Deep Brain Stimulation Systems (DBS)
- First Posted Date
- 2019-07-25
- Last Posted Date
- 2025-06-08
- Lead Sponsor
- Boston Scientific Corporation
- Target Recruit Count
- 500
- Registration Number
- NCT04032470
- Locations
- 🇧🇪
UZ Gasthuisberg, Leuven, Belgium
🇧🇪AZ Sint-Lucas, Gent, Belgium
🇧🇪AZ Delta, Roeselare, Belgium
RESPOND EDGE Post Market Study
- Conditions
- Aortic Valve Stenosis
- First Posted Date
- 2019-07-05
- Last Posted Date
- 2021-07-15
- Lead Sponsor
- Boston Scientific Corporation
- Target Recruit Count
- 200
- Registration Number
- NCT04009720
- Locations
- 🇩🇰
Rigshospitalet, Copenhagen, Denmark
🇫🇮University Helsinki, Helsinki, Finland
🇫🇷Clinique Pasteur, Toulouse, France
Radiopaque Hydrogel Spacer in Patients Undergoing Radiotherapy for Pancreatic Cancer
- Conditions
- Pancreatic Cancer
- Interventions
- Device: TraceIT Tissue Spacer implantation
- First Posted Date
- 2019-06-26
- Last Posted Date
- 2023-02-27
- Lead Sponsor
- Boston Scientific Corporation
- Target Recruit Count
- 6
- Registration Number
- NCT03998566
- Locations
- 🇺🇸
Johns Hopkins Medicine, Baltimore, Maryland, United States
🇺🇸Massachusetts General Hospital, Boston, Massachusetts, United States
🇺🇸The University of Texas MD Anderson Cancer Center, Houston, Texas, United States
Trial for A Novel Facilitated Antegrade Steering Technique in Revascularization of Coronary Chronic Total Occlusions
- Conditions
- CAD
- Interventions
- Other: single-arm study
- First Posted Date
- 2019-04-03
- Last Posted Date
- 2023-12-08
- Lead Sponsor
- Boston Scientific Corporation
- Target Recruit Count
- 20
- Registration Number
- NCT03901079
- Locations
- 🇨🇳
West China Hospital Sichuan University, Chengdu, Sichuan, China
A Clinical Trial to Confirm Safety & Effectiveness of the SYNERGY 4.50 mm and 5.00 mm Stent for Treatment of Atherosclerotic Lesion(s)
- Conditions
- Coronary Artery DiseaseHeart Diseases, CoronaryCardiovascular DiseasesAtherosclerosis
- First Posted Date
- 2019-03-15
- Last Posted Date
- 2023-12-14
- Lead Sponsor
- Boston Scientific Corporation
- Target Recruit Count
- 100
- Registration Number
- NCT03875651
- Locations
- 🇺🇸
Yale New Haven Hospital, New Haven, Connecticut, United States
🇺🇸Clearwater Cardiovascular Consultants, Clearwater, Florida, United States
🇺🇸Beth Israel Deaconness Medical Center, Boston, Massachusetts, United States
Boston Scientific's Single Shot LUMINIZE RF Balloon Catheter in the Treatment of Symptomatic, Drug Refractory Paroxysmal Atrial Fibrillation
- Conditions
- Paroxysmal Atrial Fibrillation
- Interventions
- Device: LUMINIZE RF Balloon Catheter
- First Posted Date
- 2019-02-25
- Last Posted Date
- 2021-01-15
- Lead Sponsor
- Boston Scientific Corporation
- Registration Number
- NCT03852420
Safety and Effectiveness of Jetstream Atherectomy System (J-SUPREME II)
- Conditions
- Peripheral Arterial Disease
- Interventions
- Device: Jetstream Atherectomy System
- First Posted Date
- 2019-02-20
- Last Posted Date
- 2021-08-16
- Lead Sponsor
- Boston Scientific Corporation
- Target Recruit Count
- 31
- Registration Number
- NCT03847233
- Locations
- 🇯🇵
Tokyo Bay Urayasu Ichikawa Medical Center, Urayasu, Chiba, Japan
🇯🇵Kokura Memorial Hospital, Kokura, Fukuoka, Japan
🇯🇵Tokeidai Memorial Hospital, Sapporo, Hokkaido, Japan
WATCHMAN for Concomitant Left Atrial Appendage Electrical Isolation and Occlusion to Treat Persistent Atrial Fibrillation Rhythm
- Conditions
- Persistent Atrial Fibrillation
- Interventions
- Device: Pulmonary Vein IsolationDevice: LAA IsolationDevice: LAA Occlusion
- First Posted Date
- 2019-02-08
- Last Posted Date
- 2022-03-31
- Lead Sponsor
- Boston Scientific Corporation
- Registration Number
- NCT03835338